Profile data is unavailable for this security.
About the company
China Biotech Services Holdings Limited, formerly Rui Kang Pharmaceutical Group Investments Limited is a Hong Kong-based investment holding company principally engaged in the trading of securities. The Company is also engaged in the manufacture, research and development, sales and distribution of consumer cosmetics, health related and pharmaceutical products, health supplement wine, dental materials and equipment in the People’s Republic of China (the PRC) and Hong Kong, as well as the provision of medical laboratory testing services and health check services in Hong Kong. The Company is also involved in the property holding and money lending businesses through its subsidiaries.
- Revenue in HKD (TTM)614.16m
- Net income in HKD35.89m
- Incorporated2016
- Employees215.00
- LocationChina Biotech Services Holdings LtdRoom 1213, Tower A, New Mandarin Plaza14 Science Museum RoadKowloon Hong KongHKG
- Phone+852 31883333
- Fax+852 21513968
- Websitehttp://www.cbshhk.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| New Ray Medicine International Holding | 278.24m | -32.16m | 705.27m | 28.00 | -- | -- | -- | 2.53 | -0.0192 | -0.0192 | 0.1664 | 0.3767 | 0.4366 | 3.29 | 5.26 | 9,594,310.00 | -5.05 | -6.07 | -5.17 | -6.51 | 9.39 | 14.28 | -11.56 | -19.00 | 14.17 | -- | 0.0027 | -- | 12.29 | -12.04 | -58.09 | -- | -66.60 | -- |
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 804.70m | 172.49m | 722.72m | 951.00 | 4.19 | -- | 17.02 | 0.8981 | 0.3079 | 0.3079 | 1.44 | -- | -- | -- | -- | 846,156.90 | -- | 10.43 | -- | 13.16 | 81.77 | 82.46 | 21.44 | 22.38 | -- | -- | -- | 13.63 | -3.66 | 2.91 | -12.55 | 1.47 | 59.44 | -- |
| Zhongzhi Pharmaceutical Holdings Ltd | 2.15bn | 163.43m | 837.69m | 3.40k | 4.90 | 0.7516 | 2.89 | 0.3893 | 0.1982 | 0.1982 | 2.61 | 1.29 | 1.21 | 2.74 | 6.52 | 654,328.30 | 9.22 | 9.19 | 14.00 | 12.81 | 61.55 | 60.69 | 7.60 | 8.02 | 1.28 | -- | 0.195 | 48.05 | 19.50 | 18.44 | 20.78 | 11.46 | 31.74 | -- |
| Jbm (Healthcare) Ltd | -100.00bn | -100.00bn | 840.06m | 274.00 | -- | 0.9186 | -- | -- | -- | -- | -- | 1.02 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.77 | -- | 0.2056 | -- | 4.09 | -- | -44.91 | -- | -- | -- |
| Fusen Pharmaceutical Co Ltd | 556.85m | 97.13m | 923.92m | 1.23k | 9.59 | 1.08 | 7.91 | 1.66 | 0.1251 | 0.1251 | 0.717 | 1.11 | 0.3618 | 1.88 | 6.45 | 446,192.70 | 5.83 | 7.14 | 10.14 | 17.81 | 55.44 | 53.49 | 16.11 | 18.22 | 0.6162 | -- | 0.1833 | 5.42 | 19.51 | 5.72 | 31.25 | 9.34 | 16.07 | -- |
| China Biotech Services Holdings Ltd | 614.16m | 35.89m | 1.13bn | 215.00 | 31.49 | -- | 7.88 | 1.83 | 0.0372 | 0.0372 | 0.636 | -- | -- | -- | -- | 4,760,954.00 | -- | -8.76 | -- | -11.41 | 58.64 | 46.06 | 27.02 | -18.57 | -- | 73.36 | -- | -- | 1,007.50 | 80.61 | 130.52 | -- | 66.68 | -- |
| Golden Throat Holdings Group Co Ltd | 1.00bn | 269.76m | 1.17bn | 952.00 | 4.33 | 0.7547 | 3.61 | 1.17 | 0.3649 | 0.3649 | 1.36 | 2.09 | 0.4957 | 3.09 | 3.20 | 1,068,443.00 | 13.34 | 7.95 | 18.64 | 11.13 | 73.37 | 73.11 | 26.92 | 16.66 | 2.31 | -- | 0.143 | 59.29 | -18.84 | -1.76 | -8.09 | -0.0733 | 94.32 | 0.0953 |
| Jacobson Pharma Corporation Ltd | 1.50bn | 151.24m | 1.30bn | 1.72k | 8.49 | 0.5274 | 3.63 | 0.8634 | 0.079 | 0.079 | 0.7835 | 1.27 | 0.3111 | 2.65 | 5.92 | 813,497.60 | 3.25 | 5.56 | 4.64 | 7.91 | 37.82 | 42.47 | 10.44 | 14.29 | 0.9248 | 4.95 | 0.3273 | 31.24 | -7.99 | 5.93 | -18.82 | 3.59 | -13.93 | -- |
| Austar Lifesciences Ltd | 2.01bn | 292.43m | 1.36bn | 1.45k | 4.65 | 1.51 | 4.11 | 0.6774 | 0.5705 | 0.5705 | 3.91 | 1.75 | 1.06 | 3.90 | 3.19 | 1,428,289.00 | 15.31 | -0.6462 | 35.10 | -1.28 | 25.10 | 24.96 | 14.46 | -0.7687 | 1.12 | -- | 0.1014 | -- | 23.54 | 15.61 | 309.10 | 38.98 | 13.37 | -- |
Data as of Jan 21 2022. Currency figures normalised to China Biotech Services Holdings Ltd's reporting currency: Hong Kong Dollar HKD
